Improving lung cancer screening through social health assessments
Assessing Social Determinants of Health to Increase Cancer Screening
This study is testing whether adding social health assessments to a community education program can help people aged 50 to 80 at risk for lung cancer get screened more often.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 1 site (Nutley, New Jersey) |
| Trial ID | NCT06052449 on ClinicalTrials.gov |
What this trial studies
This pilot randomized controlled trial aims to enhance lung cancer screening uptake by integrating social determinants of health (SDoH) assessments with a community-based educational tool. Participants aged 50 to 80 who are at risk for lung cancer will be recruited from community events in New Jersey. The study will compare the effectiveness of the combined intervention against the educational tool alone, measuring primary outcomes like screening uptake and secondary outcomes such as health beliefs and stigma. The goal is to identify effective strategies for increasing lung cancer screening in populations facing barriers related to social determinants.
Who should consider this trial
Good fit: Ideal candidates are men and women aged 50 to 80 who currently smoke or have quit within the last 15 years and have a significant smoking history.
Not a fit: Patients who have been diagnosed with lung cancer or have previously undergone lung cancer screening will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase lung cancer screening rates among at-risk individuals, ultimately reducing lung cancer morbidity and mortality.
How similar studies have performed: Other studies have shown success in using community-based interventions to improve cancer screening rates, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 50 years to 80 years * Currently smoke or quit smoking within the past 15 years * 20 pack-year smoking history * Has never had lung cancer screening * Able to provide informed consent * Able to speak and understand English Exclusion Criteria: * Diagnosed with lung cancer * Has a history of having a lung cancer screening scan * Unable to speak and understand English
Where this trial is running
Nutley, New Jersey
- Hackensack Meridian Health - Center for Discovery and Innovation — Nutley, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Lisa Carter-Bawa, PhD — Hackensack Meridian Health
- Study coordinator: Francis Valenzona
- Email: francis.valenzona@hmh-cdi.org
- Phone: 2018803400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.